| # | Drug | Count |
|---|---|---|
| 0 | OMALIZUMAB | 3 |
| 1 | ALBUTEROL SULFATE | 2 |
| 2 | BENRALIZUMAB | 2 |
| 3 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 2 |
| 4 | 0XYGEN | 1 |
| 5 | ALBUTEROL | 1 |
| 6 | AMLODIPINE | 1 |
| 7 | AMPICILLIN AND SULBACTAM | 1 |
| 8 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 |
| 9 | BURN RELIEF | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMPICILLIN AND SULBACTAM | 1 | 0.0011 |
| 1 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 2 | LEMBOREXANT | 1 | 0.0003 |
| 3 | ZIPRASIDONE | 1 | 0.0003 |
| 4 | FOSCARNET SODIUM | 1 | 0.0002 |
| 5 | ELOSULFASE ALFA | 1 | 0.0002 |
| 6 | ICOSAPENT ETHYL | 1 | 0.0001 |
| 7 | BENRALIZUMAB | 2 | 0.0001 |
| 8 | GANCICLOVIR SODIUM | 1 | 0.0001 |
| 9 | CHOLESTYRAMINE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-IgE [EPC] | 3 |
| 1 | Corticosteroid [EPC] | 2 |
| 2 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 2 |
| 3 | Aldosterone Antagonist [EPC] | 1 |
| 4 | Alkylating Drug [EPC] | 1 |
| 5 | Amide Local Anesthetic [EPC] | 1 |
| 6 | Antiarrhythmic [EPC] | 1 |
| 7 | Azole Antifungal [EPC] | 1 |
| 8 | Benzodiazepine [EPC] | 1 |
| 9 | Bile Acid Sequestrant [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 1 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Anti-IgE [EPC] | 3 | 0.0000 |
| 7 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 8 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |
| 9 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |